FR3036619B1 - COSMETIC ACTIVE INGREDIENT COMPRISING A CLAY WITH LAMINATED STRUCTURE, MINERAL SALTS, AMINO ACIDS AND / OR PEPTIDES AND AT LEAST ONE LIPID, AND COMPOSITIONS COMPRISING THE SAME. - Google Patents

COSMETIC ACTIVE INGREDIENT COMPRISING A CLAY WITH LAMINATED STRUCTURE, MINERAL SALTS, AMINO ACIDS AND / OR PEPTIDES AND AT LEAST ONE LIPID, AND COMPOSITIONS COMPRISING THE SAME. Download PDF

Info

Publication number
FR3036619B1
FR3036619B1 FR1554751A FR1554751A FR3036619B1 FR 3036619 B1 FR3036619 B1 FR 3036619B1 FR 1554751 A FR1554751 A FR 1554751A FR 1554751 A FR1554751 A FR 1554751A FR 3036619 B1 FR3036619 B1 FR 3036619B1
Authority
FR
France
Prior art keywords
peptides
clay
compositions
amino acids
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1554751A
Other languages
French (fr)
Other versions
FR3036619A1 (en
Inventor
Antoine Gedouin
Romuald Vallee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe de Courtage et de Diffusion SAS CODIF International
Original Assignee
Societe de Courtage et de Diffusion SAS CODIF International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Courtage et de Diffusion SAS CODIF International filed Critical Societe de Courtage et de Diffusion SAS CODIF International
Priority to FR1554751A priority Critical patent/FR3036619B1/en
Publication of FR3036619A1 publication Critical patent/FR3036619A1/en
Application granted granted Critical
Publication of FR3036619B1 publication Critical patent/FR3036619B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Principe actif cosmétique comprenant une argile à structure feuilletée, des sels minéraux, des acides aminés et/ou des peptides, et au moins un lipide choisi parmi les squalènes et/ou les céramides et présentant un pH compris entre 5 et 7. L'invention concerne en outre des compositions comprenant ce principe actif.Cosmetic active principle comprising a clay with a laminated structure, mineral salts, amino acids and / or peptides, and at least one lipid chosen from squalenes and / or ceramides and having a pH of between 5 and 7. The invention further relates to compositions comprising this active ingredient.

FR1554751A 2015-05-27 2015-05-27 COSMETIC ACTIVE INGREDIENT COMPRISING A CLAY WITH LAMINATED STRUCTURE, MINERAL SALTS, AMINO ACIDS AND / OR PEPTIDES AND AT LEAST ONE LIPID, AND COMPOSITIONS COMPRISING THE SAME. Active FR3036619B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1554751A FR3036619B1 (en) 2015-05-27 2015-05-27 COSMETIC ACTIVE INGREDIENT COMPRISING A CLAY WITH LAMINATED STRUCTURE, MINERAL SALTS, AMINO ACIDS AND / OR PEPTIDES AND AT LEAST ONE LIPID, AND COMPOSITIONS COMPRISING THE SAME.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1554751 2015-05-27
FR1554751A FR3036619B1 (en) 2015-05-27 2015-05-27 COSMETIC ACTIVE INGREDIENT COMPRISING A CLAY WITH LAMINATED STRUCTURE, MINERAL SALTS, AMINO ACIDS AND / OR PEPTIDES AND AT LEAST ONE LIPID, AND COMPOSITIONS COMPRISING THE SAME.

Publications (2)

Publication Number Publication Date
FR3036619A1 FR3036619A1 (en) 2016-12-02
FR3036619B1 true FR3036619B1 (en) 2020-02-21

Family

ID=54014980

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1554751A Active FR3036619B1 (en) 2015-05-27 2015-05-27 COSMETIC ACTIVE INGREDIENT COMPRISING A CLAY WITH LAMINATED STRUCTURE, MINERAL SALTS, AMINO ACIDS AND / OR PEPTIDES AND AT LEAST ONE LIPID, AND COMPOSITIONS COMPRISING THE SAME.

Country Status (1)

Country Link
FR (1) FR3036619B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH714167B1 (en) * 2018-02-01 2019-03-15 La Prairie Group Ag Active substance complex for cosmetic preparations.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2710527B1 (en) * 1993-09-30 1995-12-08 Roussel Uclaf New cosmetic and dermatological compositions combining ceramides and linoleic acid, their preparation.
EP0814768B1 (en) * 1995-03-14 2002-11-13 The Procter & Gamble Company Dispersed smectite clay as oil in water stabilizer for skin cleansing liquid composition
DE19543695A1 (en) * 1995-11-23 1997-05-28 Beiersdorf Ag Compositions based on alpha-hydroxyalkanoic acids and squalene, effective against bacteria, Mycota and viruses
JP2004203961A (en) * 2002-12-24 2004-07-22 Kao Corp Liquid detergent composition
FR2854897B1 (en) * 2003-05-12 2007-05-04 Sederma Sa COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS FOR REDUCING THE SIGNS OF SKIN AGING.
DE102004014615A1 (en) * 2004-03-23 2005-10-13 Beiersdorf Ag Taurine-containing preparations for improving the skin barrier
US8980344B2 (en) * 2007-10-01 2015-03-17 Dennis F. Gross Skin care products containing multiple enhancers
JP5758669B2 (en) * 2011-03-28 2015-08-05 株式会社コーセー Ceramide-containing composition

Also Published As

Publication number Publication date
FR3036619A1 (en) 2016-12-02

Similar Documents

Publication Publication Date Title
AR109170A2 (en) ACID SPHINGOMYELINASE FOR USE IN THE PREVENTION OR TREATMENT OF NIEMANN-PICK A OR B DISEASE IN A PATIENT
EP4047001A3 (en) Bicyclic urea kinase inhibitors and uses thereof
EP4292650A3 (en) Heterocyclic compounds as immunomodulators
MX2018010301A (en) Acid addition salts of piperazine derivatives.
FR3041505B1 (en) ACID COMPOSITION INCLUDING AT LEAST ONE PHYCOCYANIN STABLE AT ACIDIC PH
SMT201300109B (en) Imidazopyridazincarbonitriles useful as kinase inhibitors
BR112017024933A8 (en) ALVOCIDIB PRODUCE WITH INCREASED BIOAVAILABILITY
MA41558B1 (en) Mixed allergen compositions and methods of use thereof
PL417066A1 (en) Arginase inhibitors and their therapeutical applications
UY32682A (en) "DERIVATIVES OF 1H-IMIDAZO- [4,5-C] -QUINOLINONA"
MA51619A (en) DNA-DEPENDENT KINASE PROTEIN INHIBITORS
MA38478A1 (en) Human anti-pac1 antibodies
UY32691A (en) 1H-IMIDAZO- [4,5-C] -QUINOLINONA COMPOUNDS
EA201890771A1 (en) SALT AND SOLID FORMS OF MONOBACTAN ANTIBIOTICS
EP4335512A3 (en) Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
MA32349B1 (en) ANTAGONISTS OF THE HEDGEHOG PATHWAY BASED ON DISUBSTITUTED PHTALAZINES
BR112015020139A2 (en) therapeutic compounds and their uses
IT201900020422A1 (en) Compositions comprising strains of bacteria for use to increase the bioavailability of amino acids derived from proteins
CO2017008115A2 (en) (2s, 4r) -5- (5'-chloro-2'-fluorobiphenyl-4-yl) -4- (ethoxyoxallylamino) -2-hydroxymethyl-2-methylpentanoic acid
BR112017004393A2 (en) antibody formulations
PH12017501444A1 (en) (2r,4r)-5-(5`-chloro-2`-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
CO2019009000A2 (en) Pharmaceutical combinations to treat cancer
EA201492029A1 (en) N-ETHYL-4-HYDROXYL-1-METHYL-5- (METHYL (2,3,4,5,6-PENTAHYDROXYGEXYL) AMINO) -2-OXO-N-PHENYL-1,2-DIHYDROCHINOLIN-3-CARBOXAMIDE
WO2012054907A3 (en) Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections
FR3036619B1 (en) COSMETIC ACTIVE INGREDIENT COMPRISING A CLAY WITH LAMINATED STRUCTURE, MINERAL SALTS, AMINO ACIDS AND / OR PEPTIDES AND AT LEAST ONE LIPID, AND COMPOSITIONS COMPRISING THE SAME.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20161202

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10